Abundance of Colidextribacter
Fish oil → Abundance of Colidextribacter
Fish oil → Abundance of Colidextribacter
Evidence profile
Key finding
Serum fasting blood glucose (p = 0.039) was significantly lower in the fish oil intervention group than in the corn oil control group at three months.
This study examined the effects of fish oil-derived omega-3 fatty acids on gut microbiota and serum lipid metabolites in individuals with Type 2 Diabetes Mellitus (T2DM). The fish oil group showed significant improvements in various metabolic markers compared to the corn oil control group.
Evidence strength
Moderate confidence
Study type
RCTs
Follow-up
Extended (5–20+ y)
Quick read
The essential study design details in one scan.
Population
Young Adult (19–39), Middle Aged (40-64), Male, Female, Asia-Pacific (APAC), with T2 Diabetes
Intervention
Fish oil
Study type
RCTs
Follow-up
Extended (5–20+ y)
Primary outcome
Fasting Plasma Glucose (FPG)
Comparator
Corn Oil Group
Plain-language summary
A plain-language read of the study's main message and where it applies.
Study focus
This study examined the effects of fish oil-derived omega-3 fatty acids on gut microbiota and serum lipid metabolites in individuals with Type 2 Diabetes Mellitus (T2DM). The fish oil group showed significant improvements in various metabolic markers compared to the corn oil control group.
These findings highlight the potential of fish oil-derived omega-3 fatty acids as a therapeutic option for improving metabolic health in individuals with T2DM. By reducing fasting blood glucose and improving lipid profiles, omega-3 supplementation may contribute to better diabetes management and reduce the risk of cardiovascular complications associated with the disease.
The study was limited to a specific population with T2DM, which may affect generalizability. The duration of the intervention was relatively short at three months. Potential confounding factors were not fully explored.
Published in
Publication details and source links for this paper.
Jiayue X, Shiyu Y, Junhui Y, et al. Effects of Fish Oil-Derived Omega-3 Fatty Acids on Gut Microbiota and Serum Lipid Metabolites in T2DM. Nutrients. 2024;16(21):3755. doi:10.3390/nu16213755
Save this study and add notes to your research library.
Serum fasting blood glucose was significantly lower in the fish oil group (p = 0.039).
Glycosylated hemoglobin levels were significantly reduced in the fish oil group (p = 0.048).
Total cholesterol levels were significantly lower in the fish oil group (p < 0.001).
Evidence network
Understand where this research contributes within the broader evidence network.
This study contributes evidence to Fish oil and Abundance of Colidextribacter, Abundance of Desulfobacterota, Abundance of Haemophilus, and 12 more.
This study contributes evidence to
Primary intervention
Fish oil
Primary outcomes
Evidence topics
Primary intervention
Intervention and outcome relationships this study adds to the evidence network.
Editorial context
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
2
Related topics
15
Evidence pairs
270
Related studies
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Core evidence
The primary outcomes reported in this study.
Fish oil → Abundance of Colidextribacter
Fish oil → Abundance of Colidextribacter
Evidence profile
Fish oil → Abundance of Desulfobacterota
Fish oil → Abundance of Desulfobacterota
Evidence profile
Fish oil → Abundance of Haemophilus
Fish oil → Abundance of Haemophilus
Evidence profile
Fish oil → Abundance of Klebsiella
Fish oil → Abundance of Klebsiella
Evidence profile
Fish oil → Abundance of Lactobacillus
Fish oil → Abundance of Lactobacillus
Evidence profile
Fish oil → Abundance of Limosilactobacillus
Fish oil → Abundance of Limosilactobacillus
Evidence profile
Fish oil → Abundance of Ralstonia
Fish oil → Abundance of Ralstonia
Evidence profile
Fish oil → Fasting blood sugar (FBS)
Fish oil → Fasting blood sugar (FBS)
Evidence profile
Fish oil → Fasting Plasma Glucose (FPG)
Fish oil → Fasting Plasma Glucose (FPG)
Evidence profile
Fish oil → HbA1c
Fish oil → HbA1c
Evidence profile
Fish oil → HDL cholesterol
Fish oil → HDL cholesterol
Evidence profile
Fish oil → Insulin resistance
Fish oil → Insulin resistance
Evidence profile
Fish oil → LDL cholesterol
Fish oil → LDL cholesterol
Evidence profile
Fish oil → Total cholesterol
Fish oil → Total cholesterol
Evidence profile
Fish oil → Triglycerides
Fish oil → Triglycerides
Evidence profile
Create a free account to access effectiveness ratings, evidence strength and depth scores, consistency analysis, and direct links to all supporting studies.
Create a free account to unlock the bias score, detailed effectiveness analysis, and clinical outcomes for this study.
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on Fish oil and Abundance of Colidextribacter, Fish oil and Abundance of Desulfobacterota.
This study contributes to the evidence on the following intervention-outcome relationships.
Curated evidence collections and hubs this study is part of.
All studies measuring Abundance of Colidextribacter
Measures Abundance of Colidextribacter as a key outcome.
All studies measuring Abundance of Desulfobacterota
Measures Abundance of Desulfobacterota as a key outcome.
All studies measuring Adipokine and Angiogenic Markers
Measures Adipokine and Angiogenic Markers as a key outcome.
All studies on Fish oil
Contributes to Fish oil evidence base.
Latest published studies
Published within the last 2 years.
Jump to pre-filtered views in the evidence archive.
1 results
1 results
1 results
1 results
1 results
Generated from the study's connected evidence using Evidence Intelligence™.
Fish oil appears to improve Abundance of Colidextribacter.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Abundance of Colidextribacter
EvidenceScore™ Emerging | EvidenceScore™ 52.9 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Fish oil appears to improve Abundance of Desulfobacterota.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Abundance of Desulfobacterota
EvidenceScore™ Emerging | EvidenceScore™ 52.9 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Fish oil appears to improve Abundance of Haemophilus.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Abundance of Haemophilus
EvidenceScore™ Emerging | EvidenceScore™ 52.9 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Fish oil appears to improve Abundance of Klebsiella.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Abundance of Klebsiella
EvidenceScore™ Emerging | EvidenceScore™ 52.9 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Next steps
Choose a next path through related evidence topics, archive views, and research summaries.
Follow the topics this study contributes to.
Open broader archive views for this relationship.
Read related research summaries.
Focused on evidence, not advertising.
Your data is always protected.
New studies added every day.